CHARLES HODULIK: Open Payments
NPI 1770517898 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,743 in 124 payments from 18 companies in 2025. Trend: 2023 $2,603 · 2024 $2,245 · 2025 $2,743
Food & beverage: $2,725Education: $19
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $386 |
| ABBVIE INC. | 13 | $361 |
| Alkermes, Inc. | 12 | $325 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $264 |
| Neurocrine BioSciences, Inc. | 13 | $249 |
| E.R. Squibb & Sons, L.L.C. | 7 | $181 |
| Otsuka America Pharmaceutical, Inc. | 7 | $169 |
| Lundbeck LLC | 7 | $162 |
| Teva Pharmaceuticals USA, Inc. | 7 | $141 |
| Collegium Pharmaceutical, Inc. | 10 | $137 |
Products named: VRAYLAR, FANAPT, CAPLYTA, INGREZZA, ARISTADA, REXULTI, COBENFY, Jornay PM.
Industry payments across WI — which companies pay providers there.
